Skip to main content
. 2022 Apr 17;22:143. doi: 10.1186/s12893-022-01472-8

Table 1.

Demographic and tumor characteristics

Characteristic Number of patients Percentage (%)
N 1189 100
Age (year)
 <   40 54 4.54
 40–49 176 14.80
 50–59 348 29.27
 60–69 343 28.85
 ≥ 70 268 22.54
 Mean of age (year) 59.88
 Median of age (year, range) 60.00 (26–85)
Race
 White 942 79.23
 Black 139 11.69
 Asian or Pacific Islander 95 7.99
 American Indian/Alaska Native 9 0.76
 Unknown/other 4 0.34
Marital status
 Not married 449 37.76
 Married 699 58.79
 Unknown 41 3.45
Grade
 I/II 65 5.47
 III 223 18.76
 IV 10 0.84
 Unknown 891 74.94
Laterality
 Right 565 47.52
 Left 624 52.48
Histology
 Ductal carcinoma 476 40.03
 Lobular carcinoma 54 4.54
 Mixed type 25 2.10
 Other 634 53.32
N
 N1mi 31 2.61
 N1 721 60.64
 N2 228 19.18
 N3 209 17.58
No. of examined LN
 1–3 182 15.31
 4–9 177 14.89
 ≥ 10 675 56.77
 Other/unknown 155 13.04
No. of positive LN
 1–3 615 51.72
 4–9 212 17.83
 ≥ 10 148 12.45
 Other/unknown 214 18.00
Stage
 IB 31 2.61
 IIA 722 60.72
 IIIA 228 19.18
 IIIC 208 17.49
Surgery
 BCS 120 10.09
 Mastectomy 422 35.49
 None/unknown 647 54.42
Radiation
 Yes 688 57.86
 None/unknown 501 42.13
Chemotherapy
 Yes 929 78.13
 No/unknown 260 21.87
Type of systemic therapy
 Neoadjuvant 118 9.92
 Adjuvant 583 49.03
 Neoadjuvant + adjuvant 104 8.75
 Only systemic therapy, no surgery 28 2.35
 Other 190 15.98
 No/unknown 166 13.96
Subtypes
 Luminal A 326 27.42
 Luminal B 111 9.34
 HER2 positive 74 6.22
 Triple negative 148 12.45
 Unknown 530 44.58
ER
 Negative 414 34.82
 Borderline/unknown 100 8.41
 Positive 675 56.77
PR
 Negative 598 50.29
 Borderline/unknown 126 10.60
 Positive 465 39.11
HER2
 Negative 474 39.87
 Positive 187 15.73
 Unknown 528 44.41
Vital status
 Alive 917 77.12
 Dead 272 22.88

BCS breast-conserving surgery, MRM modified radical mastectomy, RM radical mastectomy